Trial intelligence / Profile preview

Single high-dose inhaled fluticasone for exercise-induced airway obstruction in adolescents

ISRCTN61380683Phase 3Completed

Sponsor
Stichting Pediatrisch Onderzoek Enschede
Start
Feb 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of fluticasone propionate in exercise-induced bronchospasm (EIB) (2 arms), sponsored by Stichting Pediatrisch Onderzoek Enschede. Primary endpoint: Post-bronchodilator FEV1 assessment. Started Feb 2005; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

exercise-induced bronchospasm (EIB)

Beyond the preview

Go deeper on ISRCTN61380683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN61380683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call